Glenmarkâs Sacu V is priced at INR 19 per tablet for a dose of 50mg, INR 35 per tablet for a dose of 100mg, and INR 45 per tablet for a dose of 200mg.
Glenmark Pharmaceuticals has launched the first triple fixed-dose combination (FDC) Teneligliptin with Pioglitazone and Metformin in India for treating uncontrolled type 2 diabetes.
Glenmark Pharmaceuticals (Glenmark) has received final approval by the US Food and Drug Administration (US FDA) for Nicardipine Hydrochloride capsules for 20 mg and 30 mg, the generic version of Cardene capsules of 20 mg and 30 mg of Chiesi US